Cardiac Mapping Market Research Report - Forecast till 2030

Cardiac Mapping Market : Information By Product (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems), By Indication (Atrial Fibrillation, Atrial Flutter, Avnrt And Others), By End User (Hospitals, Clinics, Diagnostic Centers) - Forecast Till 2030

ID: MRFR/HC/7314-HCR | 125 Pages | Published By Kinjoll Dey on March 2023         

Cardiac Mapping Market Speak to Analyst Request a Free Sample

Cardiac Mapping Market

The Global Cardiac Mapping Market is estimated to be USD 4.19 Billion growing at CAGR of 8.9% during forecast period of 2022-2030

$4.19 Billion

Market Size

8.9%

CAGR

North America

Dominating Region

2022-2030

Forecast Period
Segmentation
By Product Contact Cardiac Mapping Systems Non-Contact Cardiac Mapping Systems
By Indication Atrial Fibrillation Atrial Flutter Avnrt
By End User Hospitals Clinics Diagnostic Centers
Key Players
Companies Profiled •  Abbott Laboratories •  GE Healthcare •  Boston Scientific Corporation •  Medtronic plc. •  Johnson & Johnson •  Koninklijke Philips N.V. •  Hill-Rom Services Inc
Drivers
Market Driving Forces •  Manufacturers focusing on R&D to introduce refined products in the market are expected to fuel the market growth
Request a Free Sample

Cardiac Mapping Market Synopsis


The cardiac mapping market is expected to reach USD 1179.81 Million by 2030 at 8.20% CAGR during the forecast period 2022-2030.Cardiac mapping refers to the process of identifying the temporal and spatial distributions of myocardial electrical potentials during a heart rhythm. Normal functioning of the heart is affected by the presence of clots in blood vessels, aging, injury, and other lifestyle habits. Each day an average adult human heart beats 100,000 times and pumps about 2,000 gallons of blood.  

According to WHO, an estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths. This creates a huge demand for cardiac mapping devices to diagnose abnormal heart rhythms. 

Cardiac Mapping Market Influencer

An aging population and increasing incidence of cardiovascular diseases is expected to propel the cardiac mapping market.

Cardiac Mapping Market Drivers



  • Manufacturers focusing on R&D to introduce refined products in the market are expected to fuel the cardiac mapping market growth



  • The high prevalence of cardiac disorders such as coronary artery diseases, arrhythmias, congenital heart diseases, and cardiomyopathy is expected to increase the number of market entrants contributing to the growth of the cardiac mapping market. According to the CDC, one person dies every 37 seconds in the US from cardiovascular disease



  • Favorable reimbursement scenario coupled with increasing awareness among the geriatric population regarding cardiovascular diseases has anticipated the drive the growth. For instance, Medicare & Medicaid Services (CMS) proposed rule on the revisions to Medicare payment policies under the Physician Payment Schedule for the calendar year (CY) 2020, published on August 14, 2019, Federal Register (Vol. 84, No. 157 FR, pages 40482-41289)



  • The emergence of non-invasive 3D cardiac mapping systems is predicted to surge the cardiac mapping market size during the forecast period



Cardiac Mapping Market Restraints



  • Lack of trained electrophysiologists and cardiothoracic surgeons might impede the growth of the cardiac mapping market. The lack of healthcare infrastructure in developing countries and capital requirement for equipment can obstruct the growth


Cardiac Mapping Market Segmentation

By Product


  • Contact Cardiac mapping systems: This segment includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment is expected to hold a larger revenue share in the cardiac mapping market.




  • Non-contact Cardiac mapping systems: The non-contact mapping system consists of a catheter mounted multielectrode array which serves as the probe, a custom-designed amplifier system, and a computer workstation that is used to display three-dimensional maps of cardiac electrical activity.



By Indication


  • Atrial Fibrillation: Atrial fibrillation is an irregular and often rapid heart rate that occurs when the two upper chambers of heart experience chaotic electrical signals. According to the CDC, between 2.7 million and 6.1 million people in the US have Atrial Fibrillation. As the U.S. population ages, this number is expected to increase. In 2017, it was mentioned on 166,793 death certificates and was the underlying cause of death in 26,077 of those deaths. This segment holds the most significant share by revenue.

  • Atrial Flutter: Atrial flutter is a condition where the atria of the heart rapidly and regularly beat due to an anomaly in the heart's electrical system that usually results in a tachycardia

  • AVNRT: AV-nodal reentrant tachycardia (AVNRT) is an abnormally fast heart rhythm. It is a type of supraventricular tachycardia (SVT), meaning that it originates from a location within the heart above the bundle of His.

  • Wolff-Parkinson-White Syndrome: Wolff-Parkinson-White (WPW) syndrome, an extra electrical pathway between the heart's upper and lower chambers causes a rapid heartbeat. The extra pathway is present at birth and rare.

  • Others: Others include atrioventricular reciprocating tachycardia, paroxysmal supraventricular tachycardia, premature ventricular contractions, and others.


By End-User



  • Hospitals: In 2018, the hospital's segment held the largest share in the cardiac mapping market as these centers are the primary locations for patients receiving diagnosis & treatment for arrhythmiasClinics: Outpatients mostly prefer the clinics for monitoring heart diseases and routine checkup

  • Diagnostic Centers: Many diagnostic centers provide screening tests for cardiovascular diseases. The primary negative factor affecting diagnostic centers is high competition, while the primary positive factor is a low revenue volatility

  • Others: Others include research and academic institutes


By Region



  • Americas: The Americas held the largest regional cardiac mapping market share in 2018. This is owing to the high prevalence of cardiovascular diseases and the rising intermittent need for diagnosis. Hypertension, obesity, substance abuse, kidney diseases, and other conditions give rise to heart diseases, which are on the rise in the region.

  • Additionally, the presence of many hospitals in the US is likely to support cardiac mapping market growth. The US has over 32,000 cardiologists and a favorable reimbursement scenario.


  • Europe: The need for cardiac mapping is high in this region due to the aging population constantly at risk from cardiac disorders. As per Eurostat in 2016, just under two fifths (38.7 %) of all deaths among the elderly population in the EU-28 were from circulatory diseases, compared with almost one quarter (23.8 %) from cancer and less than one-tenth (8.9 %) from respiratory diseases


  • Asia-Pacific: Asia-Pacific is the fastest-growing regional cardiac mapping market for cardiac mapping. It has the world’s largest population and rapidly developing the healthcare sector. The Eastern and South Eastern-Asia are facing population aging rapidly


  • Middle East & Africa: It is estimated to account for the least share of the global cardiac mapping market due to the limited development of healthcare facilities coupled with lack of awareness regarding various circulatory disorders


Cardiac Mapping Market Key Players



  • Abbott Laboratories

  • GE Healthcare

  • Hill-Rom Services, Inc.

  • Medtronic plc.

  • Koninklijke Philips N.V.

  • Biotronik

  • Boston Scientific Corporation

  • LivaNova PLC

  • Nihon Kohden Corporation

  • Johnson & Johnson

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 1179.81 Million
  CAGR   8.20%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product, By Indication and By End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.
  Key Market Opportunities   An aging population and increasing incidence of cardiovascular diseases is expected to propel the cardiac mapping market.
  Key Market Drivers

  • Manufacturers focusing on R&D to introduce refined products in the market are expected to fuel the market growth
  • The emergence of non-invasive 3D cardiac mapping systems is predicted to surge the market size during the forecast period

    		•


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Cardiac mapping is the process of identifying the temporal and spatial distributions of myocardial electrical potentials during a heart rhythm

    The product involved in Cardiac Mapping Market are Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems

    The major key players of Cardiac Mapping Market are Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.